Top Markets
Coin of the day
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Pozycja w akcjach #33050
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Cena akcji
$0.5701
Kapitalizacja rynkowa
$6.37M
Zmiana (1 dzień)
-24.55%
Zmiana (1 rok)
-57.14%
Kraj
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategoria

Historia ceny akcji dla Citius Pharmaceuticals, Inc. (CTXR)
Najwyższa cena zamknięcia: $0.69 dnia 2026-08-01

Najniższa cena zamknięcia: $374.99 dnia 2014-10-01
Historia cen akcji firmy Citius Pharmaceuticals, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$511.97 30.34%
US
$984.83 50.62%
NL
$736.38 7.15%
CH
$1.07K -6.40%
KR
$255.62 13.43%
BE